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Abstract
Processing of miRNAs occurs simultaneous with the transcription and splicing of their primary transcripts. For the
small subset of exonic miRNAs it is unclear if the unspliced and/or spliced transcripts are used for miRNA biogenesis.
We assessed endogenous levels and cellular location of primary transcripts of three exonic miRNAs. The ratio
between unspliced and spliced transcripts varied markedly, i.e. >1 for BIC, <1 for pri-miR-146a and variable for pri-
miR-22. Endogenous unspliced transcripts were located almost exclusively in the nucleus and thus available for
miRNA processing for all three miRNAs. Endogenous spliced pri-miRNA transcripts were present both in the nucleus
and in the cytoplasm and thus only partly available for miRNA processing. Overexpression of constructs containing
the 5’ upstream exonic or intronic sequence flanking pre-miR-155 resulted in strongly enhanced miR-155 levels,
indicating that the flanking sequence does not affect processing efficiency. Exogenously overexpressed full-length
spliced BIC transcripts were present both in the nucleus and in the cytoplasm, were bound by the Microprocessor
complex and resulted in enhanced miR-155 levels. We conclude that both unspliced and spliced transcripts of exonic
miRNAs can be used for pre-miRNA cleavage. Splicing and cytoplasmic transport of spliced transcripts may present
a mechanism to regulate levels of exonic microRNAs.
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Introduction
MicroRNAs (miRNAs) are small (~22nt) noncoding RNA
molecules that negatively regulate gene expression by binding
to the 3’ untranslated region (3’ UTR) of their target mRNAs [1].
MiRNAs play an important role in cellular processes like
apoptosis, proliferation and differentiation. Altered miRNA
expression profiles have been associated with various
diseases including most, if not all, types of cancer [2]. This
suggests that regulation of miRNA levels is important for
normal cellular functioning. Regulation of the miRNA levels
may include any of the regulatory mechanisms involved in
normal gene expression, such as transcriptional or epigenetic
control of transcription. In addition to these transcriptional
regulations, miRNA levels can also be regulated at the post-
transcriptional level during miRNA processing (reviewed in 3).
The first step in miRNA processing, i.e. cleavage of the
primary miRNA transcript (pri-miRNA) by the Drosha/DGCR8
complex, is restricted to the nucleus [4-7]. The miRNA stem-
loop structures can be located in introns of protein-coding or
noncoding RNA genes, in exons of noncoding genes or in
intergenic regions [8]. The vast majority of the human miRNAs
are located in introns. Approximately 10% of the miRNAs,
including miR-155, miR-146a, miR-22, miR-137, miR-34c and
let-7b, reside within exons of noncoding genes [9-11]. Current
knowledge about processing of pri-miRNAs has been obtained
mainly for intronic or intergenic miRNAs [10,12-16]. Processing
of intronic miRNAs occurs co-transcriptionally in cooperation
with splicing of the primary transcript [10,12,13,15,16]. The
Microprocessor complex and the spliceosome are associated
in one complex, and co-produce precursor miRNAs (pre-
miRNA) and spliced transcripts from the unspliced pri-mRNA
[15]. Splicing is not required for pri-miRNA processing [10], but
spliceosome assembly may promote release of the pre-miRNA
from introns of pri-miRNA [15]. For exonic miRNAs, pre-miRNA
release will disrupt the exon of the pri-miRNA and affect
formation of spliced transcripts. Therefore, it is more likely that
unspliced pri-miRNA transcripts of exonic miRNAs produce
either pre-miRNAs or spliced transcripts. The processing of
exonic miRNAs has not yet been studied in detail.
One well-known exonic miRNA, miR-155, is processed from
the transcript of the B-cell integration cluster (BIC) gene, also
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known as the MIR155 host gene (MIR155HG) [17]. The BIC
gene consists of three exons separated by long (7.6 and 4kb)
introns and the stem-loop pre-miR-155 sequence is located in
the third exon [18]. MiR-155 is crucial for B-cell development
and regulation of the immune response [9,19,20]. High
miR-155 levels are observed in many types of cancer, including
B-cell malignancies like Hodgkin, primary mediastinal and
diffuse large B-cell lymphomas [21,22]. In contrast, very low
levels of miR-155 were observed in B cell-derived Burkitt
lymphoma [23]. Eis et al. showed that unspliced BIC is located
in the nucleus, whereas spliced BIC is located mainly in the
cytoplasm in two B-cell lymphoma cell lines that both show
high miR-155 levels [24]. RNA in situ hybridization in primary
cases of Hodgkin lymphoma and non-Hodgkin lymphomas with
high miR-155 levels revealed a strong nuclear staining of BIC
and no staining in the cytoplasm [21,23].
In this study, we investigated processing of exonic miRNAs,
with a main focus on miR-155. We determined the levels of
endogenous unspliced and spliced BIC, pri-miR-22 and pri-
miR-146a transcripts. We assessed cellular localization of
endogenous unspliced and spliced BIC, pri-miR-22 and pri-
miR-146a and showed that unspliced transcripts are located
predominantly in the nucleus while spliced transcripts are partly
transported to the cytoplasm. We also showed that the 5’
exonic or intronic flanking sequence of pre-miR-155 does not
alter processing efficiency of exogenous BIC transcripts and
that upon overexpression spliced BIC transcripts are efficiently
processed to mature miR-155.
Results
The unspliced/spliced transcript ratio is miRNA-
specific in B-cell lymphoma
For exonic miRNAs, such as miR-155, miR-22 and
miR-146a, both unspliced and spliced transcripts include the
complete stem-loop pre-miRNA sequence and may serve as
the primary miRNA transcript. To discriminate between
unspliced and spliced transcripts we designed qRT-PCR primer
sets specific for unspliced or spliced transcripts as indicated in
Figure 1A. We compared the levels of endogenous unspliced
and spliced transcripts in twenty B-cell lymphoma cell lines with
variable miRNA levels.
Endogenous miR-155 levels were highly variable in B-cell
lymphoma cell lines. The difference between the cell line with
the lowest (ST486) and the highest (OCI-Ly3) miR-155 level
was ~500 fold (Figure S1A). The median level of the unspliced
BIC transcripts was 3.7 fold higher than that of the spliced BIC
transcripts (Figure 1B). The levels of endogenous unspliced
BIC transcripts were higher than the levels of spliced BIC
transcripts in 17 out of 20 cell lines irrespective of the miR-155
levels (Figure S1B).
MiR-22 levels were low in all B-cell lymphoma cell lines
(Figure S1C). Pri-miR-22 has four alternative splice variants.
Transcript variant 3 was almost exclusively detected in our
panel of B-cell lymphoma cell lines (data not shown). We
therefore restricted our subsequent analysis to this splice
variant. The medians of endogenous levels of unspliced and
spliced pri-miR-22 were similar in 20 analyzed cell lines (Figure
1C). The spliced/unspliced pri-miR-22 transcript ratio varied
from 0.2 to 8 (Figure S1D). In SU-DHL-4 cells, the unspliced
pri-miR-22 transcript was hardly detected.
MiR-146a levels varied over a 1000-fold range between B-
cell lymphoma cell lines (Figure S1E). The levels of spliced pri-
miR-146a transcripts were significantly higher than unspliced
pri-miR-146a transcripts with a more than 20 fold difference in
medians (Figure 1D). The spliced/unspliced pri-miR-146a
transcript ratio varied from 14 to 72 fold (Figure S1F). In L540
cells only the spliced pri-miR-146a transcript was present.
Next, we correlated the mature miRNA levels with either
unspliced or spliced pri-miRNAs levels. For miR-155, both
unspliced and spliced BIC transcript levels showed significant
correlation with miR-155 levels (R2 = 0.53). The difference
observed in levels of unspliced and spliced BIC transcripts did
not result in a significant difference in the slope of the
regression lines. For miR-22, no significant correlation was
observed for either spliced or unspliced pri-miR-22 transcript
levels with mature miR-22 levels. This might be caused by
differences in the efficiency of the pri-miR-22 transcript to
miR-22 processing, differences in the miR-22 stability, factors
regulating the levels of mature miR-22 or limiting amounts of
factors involved in the biogenesis of miRNAs. For miR-146a,
both unspliced and spliced pri-miR-146a transcript levels
significantly correlated with miR-146a (R2 = 0.67 and 0.7,
respectively). However, the slopes of the curves differed
significantly (p<0.0001) due to lower unspliced pri-miR-146a
transcript levels.
Thus, for all three exonic miRNAs, both unspliced and
spliced primary transcripts are present, albeit at a variable
ratio. For BIC, the unspliced primary transcript is predominant,
for pri-miR-146a the spliced primary transcripts is predominant,
whereas for pri-miR-22 the unspliced/spliced transcript ratio
varies between cell lines. Levels of the mature miRNAs
correlated with levels of both unspliced and spliced pri-miRNA
transcripts for miR-155 and miR-146a, but not for miR-22.
Spliced pri-miRNA transcripts are partly transported to
the cytoplasm
To further examine, whether unspliced or spliced pri-miRNA
transcripts are available for miRNA processing, we examined
the subcellular localization of unspliced and spliced transcripts
of BIC, pri-miR-22 and pri-miR-146a by qRT-PCR. We
determined the amount of the spliced and unspliced transcripts
in the cytoplasm and the nucleus relative to their levels in the
total fraction (Figure 2). To asses subcellular localization of
unspliced and spliced BIC transcripts, we selected cell lines
with low (L428), intermediate (Jiyoye) or high (L540) miR-155
levels (Figure S1A). The same cell lines were used for
subcellular localization of pri-miR-22 and pri-miR-146a to allow
comparison between subcellular distributions of pri-miRNA
transcripts. We confirmed purity of the nuclear and cytoplasmic
fractions by analyzing relative abundance of tRNA-Lys in the
cytoplasm, and U3 and Xist in the nucleus (Figure S2A-C).
Endogenous unspliced BIC transcripts were located
exclusively in the nuclear fraction in all three cell lines (Figure
2A). Spliced BIC transcripts showed similar amounts in the
nucleus and in the cytoplasm. Localization of unspliced pri-
Exonic miRNA Processing
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miR-22 transcripts was predominantly, but not exclusively,
nuclear in all three cell lines (Figure 2B). Spliced pri-miR-22
transcripts were present at similar levels in the nucleus and the
cytoplasm in all three cell lines. Localization of unspliced pri-
miR-146a transcripts was exclusively nuclear for both L428 and
Jiyoye cells (Figure 2C). In L540 cells, both mature and primary
miR-146a transcripts were hardly detected, so it was not
possible to determine the subcellular localization. Spliced pri-
miR-146a transcripts were more abundant in the nucleus than
Figure 1.  The unspliced/spliced transcript ratio is miRNA-specific in B-cell lymphoma.  (A) Schematic overview of the
unspliced and spliced BIC, pri-miR-22 and pri-miR-146a transcripts and location of the qRT-PCR products specific for unspliced,
spliced and total (only for BIC) transcripts. Constructs used for miR-155 overexpression are also denoted. Short constructs, s-exBIC
and s-intBIC, contain the pre-miR-155 sequence and ~150nt 3’ flanking sequence from exon 3 and 5’ flanking sequence derived
from exon 2 (s-exBIC) or intron 2 (s-intBIC) of BIC transcript. The fl-exBIC construct covers the full-length spliced BIC transcript.
Figures are not drawn to scale. (B) The median endogenous level of unspliced BIC transcript (0.049) was 3.7 fold higher than level
of spliced BIC transcript (0.013). (C) The median endogenous level of unspliced pri-miR-22 (0.004) was similar to level of spliced
pri-miR-22 (0.006). (D) The median endogenous unspliced pri-miR-146a level (0.004) was 20.5 fold lower than that of spliced pri-
miR-146a (0.081). Levels of BIC, pri-miR-22 and pri-miR-146a were assessed in 20 B-cell lymphoma cell lines and normalized to
HPRT levels. Significance was tested with Mann-Whitney test. (E) Both spliced and unspliced BIC showed a similar significant
correlation with miR-155 levels. (F) Neither of the two pri-miR-22 transcripts showed a significant correlation with the miR-22 levels.
(G) Both unspliced and spliced pri-miR-146a levels significantly correlated with the miR-146a levels. However, the slope of the
regression line was significantly steeper for spliced pri-miR-146a.
doi: 10.1371/journal.pone.0076647.g001
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in the cytoplasm of L428 cells and in similar amounts in Jiyoye
cells.
Thus, part of the spliced BIC, pri-miR-22 and pri-miR-146a
transcripts are transported to the cytoplasm and as such
unavailable for processing. Unspliced transcripts show an
almost exclusive nuclear localization for BIC, pri-miR-22 and
pri-miR-146a. Since the levels of spliced pri-miR-22 in L540
and Jiyoye cells and pri-miR-146a in Jiyoye and L428 were
higher than the unspliced transcript levels (Figures S1D and
S1F), spliced pri-miR-22 and pri-miR-146a may still be the
predominant miRNA substrate.
Exogenous spliced BIC can be processed to miR-155
For further analysis we focused on miR-155, because
previous studies have shown conflicting data concerning BIC to
miR-155 processing [25,26]. The upstream pre-miR-155
flanking sequence is different in spliced and unspliced BIC
transcripts. To determine if this upstream sequence affects the
processing efficiency, we assessed the levels of miR-155
induction upon overexpression of BIC from two short fragments
of BIC containing the stem-loop region, ~150nt 3’ flanking
sequence from exon 3 and ~150nt 5’ flanking sequence
derived either from intron 2 (s-intBIC) or from exon 2 (s-exBIC)
of BIC transcript (Figure 1A). In addition, we also
overexpressed the full-length spliced BIC (fl-exBIC) transcript
(Figure 1A). We transduced these three BIC constructs into
ST486, Ramos and U-HO1, i.e. cells that all have low
endogenous miR-155 levels. A high expression of BIC was
induced using either of the constructs (Figure 3A), albeit at
variable levels. Transduction with the short exon spanning BIC
construct resulted in the highest increase and the full-length
spliced BIC construct resulted in the lowest increase in total
BIC transcript levels (Figure 3A). Interestingly, the level of
miR-155 induction was similar for all three constructs (Figure
3B), despite the marked differences in total BIC levels. These
data indicate that the upstream pre-miR-155 flanking sequence
does not modify processing efficiency and suggest that at a
certain level of primary miRNA transcript, other factors become
limiting or regulate the level of mature miR-155.
Next, we determined the subcellular localization of BIC
transcripts in Ramos cells transduced with fl-exBIC (Figure
3C). Purity of cytoplasmic and nuclear fractions was validated
with tRNA-Lys and U3, respectively (Fig. S2DE). In empty
vector control cells, and in cells with overexpressed fl-exBIC,
localization of endogenous unspliced BIC transcripts was
predominantly nuclear. The endogenous spliced BIC
transcripts were not detectable in empty vector control cells.
The amount of the overexpressed fl-exBIC transcripts was
similar in the cytoplasmic and nuclear fractions.
Overexpression of fl-exBIC was followed by a strong induction
of miR-155 (Figure 3B), indicating that upon overexpression
nuclear spliced BIC transcripts can also serve as the primary
miR-155 transcript.
To show that exogenous spliced BIC is processed to
miR-155, we determined whether it is a direct target of the
Microprocessor complex. We performed immunoprecipitation of
DGCR8 [27] in wild-type Jiyoye, Ramos fl-exBIC and U-HO1 fl-
exBIC cells (Figure 3D-F and Figure S3A-C). We assessed the
relative amounts of unspliced and spliced BIC transcripts in the
DGCR8 immunoprecipitation fraction (DGCR8-IP) compared to
the control IgG-IP. Unspliced BIC transcript was significantly
more enriched in DGCR8-IP fraction of all three cell lines, albeit
at variable levels (Figure 3D). Similarly, the endogenous and
exogenous spliced BIC transcripts were significantly enriched
in DGCR8-IP fraction of Jiyoye, U-HO1 fl-exBIC and Ramos fl-
exBIC cells (Figure 3E). The HPRT transcript used as negative
Figure 2.  Cellular localization of unspliced and spliced pri-miRNA transcripts.  (A) Unspliced BIC transcript levels were
significantly higher in the nucleus than in the cytoplasm, whereas spliced BIC transcripts showed similar levels. (B) Unspliced pri-
miR-22 transcripts were more abundant in the nucleus than in the cytoplasm and spliced pri-miR-22 transcript levels were similar.
(C) Unspliced pri-miR-146a transcripts were almost exclusively in the nucleus, and spliced pri-miR-146a transcripts were both in the
nucleus and in the cytoplasm. Unspliced and spliced pri-miR-146a transcripts were not detectable in L540 cells. Levels of pri-miRNA
transcripts in the nucleus or the cytoplasm were calculated relative to their levels in the total fraction and corrected for the amount of
RNA per cell. Average of three independent experiments was presented. Significance was calculated using 2-way ANOVA and
Bonferroni posttest (* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001, ns - not significant).
doi: 10.1371/journal.pone.0076647.g002
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control was not enriched in the DGCR8-IP fractions (Figure
3F). Enrichment of endogenous and exogenous spliced BIC in
the DGCR8-IP fractions indicate that the spliced primary
transcript can be used for miR-155 processing.
The unspliced/spliced ratio of BIC transcripts changes
upon cellular activation
To investigate whether the ratio between unspliced and
spliced BIC transcripts is altered upon induction of BIC, we
activated three B-cell lymphoma cell lines using PMA/
Ionomycin. Activation of DG-75, L428 and KM-H2 cells resulted
in a 3- to 13-fold increase in miR-155 levels (Figure 4A).
Induction of unspliced BIC transcript levels showed a 1.6 to 5.5
fold increase, whereas spliced BIC transcript levels showed a
5.4 to 31 fold increase compared to untreated cells (Figure 4B).
Although the unspliced BIC transcript remained the
predominant transcript, the unspliced/spliced BIC transcript
ratio significantly changed in favour of the spliced BIC
transcript (Figure 4C). Thus, both processing of unspliced BIC
transcript to miR-155 and to spliced BIC transcripts are
enhanced upon activation-induced expression of BIC. In
addition, we also assessed induction of mature miR-146a and
miR-22 as well as two intronic miRNAs (miR-191, miR-16) and
one intergenic miRNA (let-7a). Induction of mature miRNA
levels upon PMA/Ionomycin stimulation was observed only for
the three exonic miRNAs (Figure S4). Both unspliced and
spliced pri-miR-146a and pri-miR-22 transcript levels were
Figure 3.  Processing and cellular localization of exogenous BIC transcripts.  Levels of total BIC (A) and miR-155 (B)
determined upon overexpression of the three constructs and empty vector (EV) in ST486, Ramos and U-HO1 cells. For the three
BIC overexpression constructs, the increase in total BIC was variable and the highest levels were observed for the short BIC
transcript containing the exon 2-derived 5’ pre-miR-155 flanking sequence (s-exBIC). However, miR-155 induction was similar for all
BIC overexpression constructs. (C) The levels of spliced and unspliced BIC transcripts in nuclear and cytoplasmic fractions of
Ramos EV and Ramos full-length spliced BIC (fl-exBIC). For both Ramos EV and fl-exBIC, unspliced BIC showed significantly
higher (p<0.001) levels in the nucleus than in the cytoplasm. Spliced BIC was not detectable (ND) in Ramos EV. Upon
overexpression of the fl-exBIC construct, spliced BIC transcripts showed similar levels in the cytoplasm and in the nucleus.
Transcript levels in the cytoplasm and the nucleus were calculated relative to the total fraction and corrected for the amount of RNA
per cell. Average of three independent experiments was presented. P values were determined by 2-way ANOVA and Bonferroni
posttest (** p<0.01, ns - not significant). Relative amounts of unspliced (D) and spliced (E) BIC transcripts in DGCR8-IP compared
to IgG-IP in Jiyoye, Ramos fl-exBIC and U-HO1 fl-exBIC cells. Endogenous unspliced, endogenous spliced and exogenous spliced
BIC transcripts were significantly enriched in DGCR8-IP compared to IgG-IP. (F) No enrichment of HPRT transcript was observed in
DGCR8-IP. Amounts were calculated relative to tRNA-Lys levels. P values were determined by Student’s t-test (** p<0.01, ***
p<0.001, **** p<0.0001, ns - not significant).
doi: 10.1371/journal.pone.0076647.g003
Exonic miRNA Processing
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induced upon PMA/Ionomycin treatment (Figure S4), however,
no difference was observed for the unspliced/spliced
transcripts ratios (Figure S4). Thus, the change in unspliced/
spliced transcript ratio upon stimulation is specific for the BIC
transcript.
Discussion
Exonic miRNAs constitute a small group of the known human
miRNAs. The vast majority of exonic miRNAs are located in
noncoding RNA genes of which the only known function is
being the miRNA host gene. In contrast to intronic miRNAs,
processing of the pri-miRNA transcripts of exonic miRNAs to
pre-miRNAs interferes with the normal splicing process of the
transcript. Exonic miRNAs regulate important physiological
pathways, i.e. miR-155 and miR-146a are crucial regulatory
components of the immune response, hematopoiesis and
carcinogenesis (reviewed in 28,29) and miR-22 plays a role in
carcinogenesis [30,31].
In this study, we showed that unspliced pri-miRNA
transcripts of exonic miRNAs, i.e. miR-155, miR-22 and
miR-146a, are located predominantly in the nucleus. The
spliced transcripts are present both in the nucleus and the
cytoplasm. Since the first processing step of pri-miRNAs takes
place in the nucleus [32,33], both nuclear unspliced and spliced
transcripts can serve as pri-miRNA templates. This was
supported by presence of both unspliced and spliced BIC
transcripts in the DGCR8-containing Microprocessor complex.
Overexpression constructs containing either the exonic 5’
flanking sequence or the intronic 5’ flanking sequence of pre-
miR-155 both resulted in a marked miR-155 induction.
Consistent with these findings we also observed a marked
induction of miR-155 in cells with overexpressed full-length
spliced BIC transcripts. These data also indicate that the
Microprocessor complex can use unspliced and spliced BIC
 transcripts for processing to pre-miR-155. Since the unspliced
BIC transcripts are much more abundant and are almost
exclusively located in the nucleus, we conclude that unspliced
nuclear BIC transcripts are the primary template for miR-155
processing in B-cell lymphoma. In contrast to pri-miR-155, the
spliced transcripts are the most abundant form of pri-miR-146a
and, for part of the cell lines of pri-miR-22. Unspliced pri-
miR-146a showed very low levels in all cell lines. This might
indicate that the unspliced pri-miR-146a is directly used for
processing to pre-miR-146a or for splicing. The level of spliced
pri-miR-146a might thus represent the level of pri-miRNA that
was not used for miRNA processing. Alternatively, despite the
partial cytoplasmic location, the spliced transcripts can still be
the most important source for the biogenesis of mature
miR-146a. Overexpression of miRNAs from constructs that do
not contain introns show very effective processing to mature
miRNAs, similar to our results using the BIC constructs. This
indicates that although splicing enhances processing [12,15], it
is not required to allow efficient processing to mature miRNAs.
Pawlicki et al. showed that overexpressed pri-miRNAs that are
artificially prematurely released from the transcription site
accumulate in the nucleoplasm and are not efficiently
processed to pre-miRNA [13,34]. These studies implicate that
spliced pri-miRNA transcripts may be less efficient templates
for the miRNA processing machinery when released from the
transcription site. Effective in vitro processing of pri-miRNAs
using whole-cell extract or immunoprecipitated Microprocessor
[6] indicates that presence of the transcript at the
transcriptional start site is not required for pre-miRNA release.
Although we do not know if spliced exonic pri-miRNA
transcripts are released from the transcription start site before
miRNA processing, our data clearly show that spliced
transcripts can be used for miRNA processing.
We observed that induction of BIC using three different
constructs was variable. However, the induction of mature
Figure 4.  Induction of unspliced and spliced BIC transcripts upon cellular activation.  Fold induction in miR-155 (A),
unspliced BIC and spliced BIC transcript (B) levels upon PMA/Ionomycin (P/I) treatment. Levels of miR-155 and BIC transcripts in
untreated cells were averaged and fold induction upon P/I treatment was calculated. In all three cell lines, induction of spliced BIC
was higher than of unspliced BIC transcripts. (C) Unspliced BIC transcripts were predominant in both untreated and P/I-treated
cells, however unspliced/spliced BIC ratio significantly decreased upon P/I treatment. Sum of spliced and unspliced BIC transcript
levels was set as 100%. Average of three (DG-75 and L428) or four (KM-H2) experiments was presented. P values were
determined by a Student’s t-test (* p<0.05, ** p<0.01, ns - not significant).
doi: 10.1371/journal.pone.0076647.g004
Exonic miRNA Processing
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miR-155 was strikingly similar in the three cell lines. Thus,
induction of higher BIC transcripts levels did not result in higher
miR-155 levels. This suggests that the miR-155 levels are
regulated in these cell lines characterized by very low
endogenous miR-155 levels. Notably, the level of miR-155
obtained with these three constructs was still ~10 fold lower
than the highest observed endogenous miR-155 levels in OCI-
Ly3 cell line. An alternative explanation could be that factors
required for miRNA biogenesis become limiting and preclude
induction of higher levels.
For BIC, we demonstrated that part of the spliced transcripts
are exported to the cytoplasm and are thus not available for
processing. Similarly, spliced pri-miR-22 and to a lesser degree
spliced pri-miR-146a are exported to the cytoplasm. Alteration
of the efficiency of splicing and nuclear export of spliced pri-
miRNA transcripts may rapidly change the amount of pri-
miRNA available for miRNA processing and therefore serve as
a mechanism to regulate mature miRNA levels. Consistent with
this hypothesis, we observed differences in the ratio of
unspliced to spliced BIC transcript levels upon PMA/Ionomycin
treatment. Cellular conditions and external stimuli may thus
affect exonic miRNA levels by inducing changes to the amount
of unspliced pri-miRNA used for miRNA processing at the
expense of the amount of unspliced transcript available for
splicing.
Both unspliced and spliced exonic miRNA transcripts can be
used as substrate for miRNA processing. The level and ratio of
spliced and unspliced transcripts, their cellular location and the
processing efficiency together determine which form is the
most likely endogenous pri-miRNA. For exonic miRNA
processing studies it is important to assess total transcript
levels and not only examine either spliced or unspliced
transcripts. Conflicting data as presented in the current
literature concerning the processing efficiency of BIC may, at
least partially, be explained by differences in the analyzed
transcripts [25,26].
Many proteins were reported to inhibit or promote miRNA
processing by binding to stem-loop of pri-miRNA and/or pre-
miRNA (reviewed in 3). These proteins have been identified to
regulate both intronic and exonic miRNA processing. KH-type
splicing regulatory protein (KSRP) was shown to enhance
miR-155 processing in mouse activated macrophages by
binding to the terminal loop of both BIC transcript and pre-
miR-155 [35]. Moreover, monocyte chemoattractant protein
[MCP]-1-induced protein 1 (MCPIP1) was shown to suppress
miRNA processing of a panel of miRNAs, including miR-155
and miR-146a, by induction of pre-miRNA terminal loops
cleavage [36]. Some of these proteins, like KSRP or hnRNPA1,
regulate both miRNA and mRNA processing [37-39]. These,
and possibly other, regulatory proteins may thus regulate
exonic miRNA levels by promoting either pre-miRNA cleavage
or splicing of exonic pri-miRNA transcripts.
It is unclear whether cytoplasmic spliced pri-miRNA
transcripts have a function in the cytoplasm. To date, the only
known function of the three noncoding genes studied in this
paper is being the host gene for the miRNAs. Splicing of the
transcripts and the subsequent transport to the cytoplasm
might serve as a mechanism to prevent processing to pre-
miRNA (Figure 5). This is supported by the finding that upon
inhibition of DGCR8 with shRNA in L1236 cells we saw a
marked induction of the spliced BIC transcript, which resulted
in a change of the unspliced/spliced BIC transcript ratio from
2.5 to 0.3 (data not shown). This indicates that when pri-miRNA
processing is inhibited, splicing of unspliced BIC transcript is
enhanced. Another possible role of the cytoplasmic spliced
transcripts is that they may function as competing endogenous
RNA (ceRNA) transcripts for the mature miRNAs. MiR-155 and
miR-155* sequences are highly complementary and the BIC
transcript is a predicted miR-155 target by the miRanda-
mirSVR and PITA algorithms (http://www.microrna.org [40];
http://genie.weizmann.ac.il/pubs/mir07/mir07_prediction.html
[41]). Up to date, various transcripts were shown to function as
ceRNA, e.g. protein-coding transcripts, pseudogenes, and long
noncoding RNAs [42-44]. Spliced pri-miRNA transcripts of
exonic miRNAs could prevent binding of the mature miRNA to
their endogenous protein-coding target genes and thereby
prevent efficient knock down of the target proteins. This would
be a novel mechanism, by which cytoplasmic pri-miRNA
transcripts function in a negative feedback-back loop to
regulate miRNA function. Another possibility is that pri-miRNAs
are processed in the cytoplasm, similar to Drosha-mediated
processing of viral pri-miRNAs that was shown to take place in
the cytoplasm [45]. In these cells relocalization of Drosha to the
cytoplasm and the subsequent pri-miRNA processing was
triggered by viral infection. This implicates that Drosha
relocalization might potentially also occur in normal cells under
certain conditions.
In conclusion, we showed that unspliced BIC, pri-miR-146a
and pri-miR-22 transcripts were predominantly localized in the
nucleus, although spliced transcripts are more abundant in
Figure 5.  Model of processing of exonic primary miRNA
transcripts.  The classical miRNA processing and functioning
pathway (indicated in dark) shows that the predominant pri-
miRNA transcript, i.e. the unspliced nuclear transcript, is
processed to pre-miRNA. Pre-miRNA is transported to the
cytoplasm and further processed to mature miRNA. Mature
miRNA guides the RNA-induced silencing complex (RISC) to
protein-coding miRNA targets to inhibit their expression.
Unspliced transcripts can also be spliced before being
processed to pre-miRNA. Alternatively, the spliced transcript
can also be transported to the cytoplasm. This may represent a
mechanism to prevent processing to pre-miRNA.
doi: 10.1371/journal.pone.0076647.g005
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some cases. We also showed that spliced BIC, pri-miR-146a
and pri-miR-22 transcripts are partly localized in the cytoplasm
and thus not fully available for processing to the mature
miRNAs. Pre-miRNAs and spliced transcripts appear to be two
mutually exclusive products of unspliced pri-miRNA transcripts
of exonic miRNA. Splicing and transport to the cytoplasm may
represent a novel mechanism to regulate cellular exonic
miRNA levels and function.
Materials and Methods
Cell lines and treatment
Burkitt lymphoma cell lines (Ramos, DG-75, ST486,
NAMALWA, Raji, Jiyoye) were purchased from ATCC (ST486)
and DSMZ (other cell lines). Diffuse large B-cell lymphoma cell
lines (OCI-Ly3, SU-DHL-4, SU-DHL-6, VER) were a kind gift of
A. Rosenwald (University of Würzburg, Germany) (OCI-Ly3)
[46,47], A. Epstein (UCLA, CA) (SU-DHL-4 and SU-DHL-6)
[46,47] or were established in our laboratory (VER) [48].
Hodgkin lymphoma cell lines (L540, L591, L1236, DEV, KM-
H2, HDLM-2, L428, U-HO1) were purchased from DSMZ
(L540, KM-H2), were a kind gift of V. Diehl (University of
Cologne, Germany) (L591 [49], L1236 [50], HDLM-2 [49], L428
[51,52]) and P. Möller (University of Ulm, Germany) (U-HO1)
[53] or were established in our laboratory (DEV) [54]. Primary
mediastinal B-cell lymphoma cell lines (KARPAS-1106P,
MEDB-1) [55] were a kind gift of M. Dyer (University of
Leicester, UK). Cell lines were cultured at 37°C under an
atmosphere containing 5% CO2 in Iscove's Modified Dulbecco's
Medium (OCI-Ly3) or RPMI-1640 (other cell lines) medium
(Cambrex Biosciences, Walkersville, USA) supplemented with
ultraglutamine (2 mM), penicillin (100 U/ml), streptomycin (0.1
mg/ml; Cambrex Biosciences), and 5% (L428), 20% (DEV,
ST486, OCI-Ly3) or 10% (other cell lines) fetal calf serum
(Cambrex Biosciences). DG-75, L428 and KM-H2 cells were
treated for 24h with Phorbol 12-myristate 13-acetate (PMA)/
Ionomycin (both Sigma-Aldrich, Saint Louis, MO) as previously
described [25]. The PMA/Ionomycin treatment was performed
in triplicate (DG-75 and L428) or quadruplicate (KM-H2).
BIC/miR-155 constructs
The pcDNA3.1(+) plasmid containing full-length spliced BIC
(fl-exBIC) was described previously [25]. The MXW-PGK-IRES-
GFP vector was a kind gift from C-Z. Chen (Stanford
University, CA). The full-length spliced fl-exBIC insert was
subcloned from the pcDNA3.1(+) vector to the MXW-PGK-
IRES-GFP vector using PmeI (pcDNA3.1(+) vector) and HpaI
(MXW-PGK-IRES-GFP vector) restriction enzymes. The
miR-155 stem-loop and ~150nt flanking sequences were
amplified from genomic DNA (s-intBIC) or cDNA (s-exBIC)
using Taq polymerase. Primer sequences used for PCR were
as follows, 5’-TGTCACCTCCAGCTTTATAACC-3’ (forward, s-
intBIC), 5’-AACCTACCAGAGACCTTACC-3’ (forward, s-
exBIC), 5'-GGCTTTATCATTTTTCAATCT-3 (reverse, s-intBIC
and s-exBIC). An XhoI restriction site was added to the forward
and an EcoRI site to the reverse primer to allow efficient
cloning. PCR products were cloned to the retroviral MXW-PGK-
IRES-GFP vector using standard laboratory procedures. The
inserts were sequenced to confirm the correct sequences.
Retroviral transduction
To generate retroviral particles, Phoenix-Ampho packaging
cells [56] were CaPO4 transfected with 37,5μg of MXW-PGK-
IRES-GFP constructs (empty vector or vector containing one of
the BIC constructs) in T75 flasks. Viral particles were harvested
after two days and concentrated with Retro-X concentrator
(Clontech, Saint-Germain-en-Laye, France) according to the
manufacturer’s protocol. Target cells were transduced with the
virus by spinning at 2,000rpm for 2hrs. Cells transduced with
retroviral vectors were sorted for GFP using MoFlo sorter
(Dako cytomation).
RNA isolation from total, nuclear and cytoplasmic
fractions
Nuclear and cytoplasmic fractions were separated by adding
200µl of lysis buffer (140mM NaCl, 1.5mM MgCl2, 10mM Tris-
HCl pH8.0, 1mM DTT, 0.5% Nonidet P-40) to pellets of ~4
million cells, followed by 5min incubation on ice and
centrifugation for 3min at 4°C and 100xg. The supernatant was
harvested as the cytoplasmic fraction. The pellet containing the
nuclei was washed twice with lysis buffer. 1ml of Qiazol
(Qiagen, Carlsbad, USA) was added to the ~200µl of
cytoplasmic fraction, to the nuclear pellet and to the total cell
pellet.
Quantitative RT-PCR
Total RNA was isolated using Trizol (Invitrogen, Carlsbad,
USA) according to the manufacturer’s protocol for the cell lines.
RNA samples were treated with DNase (Ambion, Foster City,
CA). The RNA concentration was measured with a NanoDropTM
1000 Spectrophotometer (Thermo Fisher Scientific Inc.,
Waltham, USA) and RNA integrity was evaluated by 1%
agarose electrophoresis. cDNA was synthesized using 500ng
input RNA, SuperScript II and random primers according to the
manufacturers protocol (Invitrogen). The qPCR reaction
contained SYBRgreen mix (Applied Biosystems, Foster City,
USA), 300nM primers, and 1ng of cDNA in a total volume of
10µl. Levels of spliced, unspliced and total BIC as well as
spliced and unspliced pri-miR-22, pri-miR-146a were
normalized to HPRT. For cytoplasmic, nuclear and total
fractions, qRT-PCR was performed as described above with
slight modifications. We used the miRNeasy kit (Qiagen)
including a DNase-treatment (Qiagen) for RNA isolation. RNA
was diluted in the same way for total and cytoplasmic fractions
and 5 times less for nuclear fraction to use similar amounts
(~500ng) for cDNA synthesis. 1/500 of the cDNA was used for
qRT-PCR. Ct values of nuclear fractions were corrected for
different RNA dilutions. Transcript levels in nuclear and
cytoplasmic fraction were calculated relative to total fraction.
Purity of nuclear fractions was confirmed with U3 and Xist and
of the cytoplasmic fraction with tRNA-Lys. For qRT-PCR the
following primer sequences used were: for unspliced BIC, 5’-
AGCTTTATAACCGCATGTGCATAC-3’ (forward) and 5’-
CAGATTTCCCCTTCCTGGTTT-3’ (reverse); for total BIC, 5’-
AAATTCTTTATGCCTCATCCTCTGA-3’ (forward) and 5’-
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AGGCAAAAACCCCTATCACGAT-3’ (reverse); for unspliced
pri-miR-22, 5’-CTGCTCAGATCTTTCCCATTTTC-3’ (forward)
and 5’-CCAGGTGAGGGCGTGAGA-3’ (reversed); for spliced
pri-miR-22, 5’-GGGCTGATCACTGAACTCACATT-3’ (forward)
and 5’-TGAGGGCGTGAGAGGAACA-3’ (reversed), for
unspliced pri-miR-146a, 5’-
ATTTACCAGGCTTTTCACTCTTGTATT-3’ (forward) and 5’-
GGCTTTTCAGAGATGGTGCAA-3’ (reverse); for spliced pri-
miR-146a, 5’-GACAGGAGACAGTAGCACAACGA-3’ (forward)
and 5’-CAGCCAGCGAGCTCCTAAAA-3’ (reverse); for Xist, 5’-
GTCCTTTCTTTTGACCCCAGAA-3’ (forward) and 5’-
GAGCCTGGCACTTTTTTTTCC-3’ (reverse); primers for
spliced BIC, HPRT, tRNA-Lys and U3 were described
previously [21,57,58]. Localization of unspliced or spliced
transcript-specific qRT-PCR products are indicated in Figure
2A. qRT-PCR for miR-155, miR-22, miR-146a, miR-16,
miR-191, let-7a and RNU48 was performed using miRNA qRT-
PCR assays (Applied Biosystems, Foster City, USA) as
described previously [59]. Reverse transcription (RT) primers
specific for a miRNA and RNU48 (control) were multiplexed in
15µl RT reactions containing 1µl of each RT primer. The
miRNA levels were normalized to the RNU48 levels. Mean
cycle threshold (Ct) values for all genes were quantified with
the SDS software (version 2.1). Relative expression levels
were calculated as 2-∆Ct.
DGCR8 immunoprecipitation
Immunoprecipitation of DGCR8-containing Microprocessor
complexes was performed as described previously for Ago2-IP
with some slight modifications [60]. Briefly, ~30 million cells
were lysed with 100 µl of the same lysis buffer as used for the
cellular fractionation and sonicated for 5 seconds. Lysate was
incubated with protein A Sepharose beads (GE Healthcare)
coated with anti-DGCR8 antibody (ab90579, Abcam,
Cambridge, UK) at 4°C overnight. Mouse IgG antibody was
used as a negative control (Millipore BV, Amsterdam, The
Netherlands). After washing the beads, RNA was harvested for
qRT-PCR analysis and protein lysates were prepared for
Western blot. Western blot for DGCR8 was performed as
described previously [60], using a 1:2000 dilution of the
DGCR8 antibody at 4°C overnight. Total RNA was isolated with
miRNeasy Kit (Qiagen) according to manufacturer’s protocol.
RNA from DGCR8-IP and IgG-IP fractions of Jiyoye, U-HO1 fl-
exBIC and Ramos fl-exBIC cells was used for qRT-PCR
analysis. Levels of unspliced and spliced BIC transcripts in
DGCR8-IP and IgG-IP fraction were calculated relative to
tRNA-Lys and fold increase in the DGCR8-IP fraction was
calculated for each sample.
Supporting Information
Figure S1.  The endogenous levels of mature miRNAs,
unspliced and spliced pri-miRNAs of miR-155, miR-22 and
miR-146a in B-cell lymphoma. The levels of miR-155 (A),
miR-22 (C) and miR-146a (E) in the cell line panel were sorted
from low to high. Unspliced and spliced transcripts levels of
BIC (B), pri-miR-22 (D) and pri-miR-146a (F) in 20 B-cell
lymphoma cell lines. In 17 out of 20 cell lines the levels of
unspliced BIC transcripts were higher than the levels of spliced
BIC transcripts. Spliced pri-miR-22 transcript levels were higher
than unspliced pri-miR-22 transcript levels in 9, similar in 9 and
lower in 2 of the analyzed cell lines. In all tested cell lines,
levels of spliced pri-miR-146a were much higher than unspliced
pri-miR-146a transcripts. Levels of BIC, pri-miR-22 and pri-
miR-146a were normalized to HPRT and levels of miR-155,
miR-22 and miR-146a were normalized to RNU48.
(TIF)
Figure S2.  Validation of nuclear and cytoplasmic fraction
purity. (A) Cytoplasmic control, tRNA-Lys, was mostly present
in the cytoplasmic fraction of L428, L540 and Jiyoye cells.
From the two nuclear controls, U3 and Xist, U3 (B) showed
slightly higher level in the nucleus and Xist (C) was exclusively
nuclear in the two female cell lines, L428 and L540. Similarly,
for Ramos EV and Ramos fl-exBIC, tRNA-Lys (D) was more
abundant in the cytoplasm and U3 (E) more abundant in the
nucleus. Amount of transcripts was calculated relative to the
total fraction and corrected for the amount of RNA per cell.
Average of 3 experiments was shown.
(TIF)
Figure S3.  Validation of DGCR8-IP fractions. (A) Western
blot for DGCR8 in Ramos fl-exBIC cells. DGCR8 was pulled
down with anti-DGCR8 antibody and not with the non-specific
IgG control. (B) Levels of unspliced and spliced BIC transcripts
in total fractions of Jiyoye, Ramos fl-exBIC and U-HO1 fl-exBIC
cells. Levels of exogenous spliced BIC transcripts were much
higher than endogenous unspliced BIC transcripts for Ramos
and U-HO1. (C) Relative amounts of unspliced and spliced BIC
transcripts in DGCR8-IP fractions were similar in Jiyoye cells.
In the Ramos and U-HO1 cell lines, exogenous spliced BIC
transcripts were much more abundant in the DGCR8-IP
fraction than unspliced BIC transcripts.
(TIF)
Figure S4.  Induction of miR-22 and miR-146a upon cellular
activation. Fold induction in levels of miR-22 (A), unspliced
and spliced pri-miR-22 (B) in cells treated with PMA/Ionomycin
(P/I). Levels of miR-22 were increased in 2 out of 3 cell lines.
Levels of unspliced and spliced pri-miR-22 were increased in
all tested cell lines. (C) No difference in pri-miR-22 unspliced/
spliced ratio was observed upon P/I treatment. Mature
miR-146a (D), unspliced and spliced pri-miR-146a (E)
transcript levels were also higher P/I-treated cells. (F) Pri-
miR-146a unspliced/spliced ratio was not altered upon cellular
activation. No differences in levels of intronic miRNAs, miR-16
(G) and miR-191 (H), or intergenic let-7a (I) were observed.
Average of 3 experiments was presented. Student’s t-test was
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